Cargando…
Adiponectin Agonist ADP355 Attenuates CCl(4)-Induced Liver Fibrosis in Mice
Liver fibrosis is a growing global health problem characterized by excess deposition of fibrillar collagen, and activation of hepatic stellate cells (HSCs). Adiponectin is known to possess anti-fibrotic properties; however a high physiological concentration and multiple forms circulating in blood pr...
Autores principales: | Kumar, Pradeep, Smith, Tekla, Rahman, Khalidur, Thorn, Natalie E., Anania, Frank A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195748/ https://www.ncbi.nlm.nih.gov/pubmed/25310107 http://dx.doi.org/10.1371/journal.pone.0110405 |
Ejemplares similares
-
C/EBP homologous protein modulates liraglutide-mediated attenuation of non-alcoholic steatohepatitis
por: Rahman, Khalidur, et al.
Publicado: (2016) -
Adiponectin-Based Peptide (ADP355) Inhibits Transforming Growth Factor-β1-Induced Fibrosis in Keloids
por: Darmawan, Claudia C., et al.
Publicado: (2020) -
Adiponectin-derived active peptide ADP355 exerts anti-inflammatory and anti-fibrotic activities in thioacetamide-induced liver injury
por: Wang, Huafeng, et al.
Publicado: (2016) -
Corrigendum: Adiponectin-derived active peptide ADP355 exerts anti-inflammatory and anti-fibrotic activities in thioacetamide-induced liver injury
por: Wang, Huafeng, et al.
Publicado: (2016) -
Blockade of CCN4 attenuates CCl(4)-induced liver fibrosis
por: Li, Xiaofei, et al.
Publicado: (2015)